Learn about neck pain causes, evaluation, management, and prevention strategies to maintain a healthy neck in the digital age ...
For the first time, patients with abnormal cells detected in their bone marrow have a treatment option before the condition ...
22hon MSN
Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients
Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the Western Hemisphere, affecting approximately ...
UNC School of Medicine researchers have led an international clinical trial of patients with generalized myasthenia gravis, ...
More than 140,000 bottles of a popular drug commonly prescribed to reduce cholesterol have been recalled for a defect that ...
He was told cancer would kill him in two to four years. Fourteen years later, he credits a series of medications and ...
1. Willi R, Bril V, Howard J, et al. RELIEVE: a phase 3 study evaluating the efficacy and safety of remibrutinb in generalized myasthenia gravis. Presented at: American Association of Neuromuscular & ...
News-Medical.Net on MSN
Combination therapy offers hope for ending lifelong chronic lymphocytic leukemia treatment
Ianalumab targets the B-cell activating factor receptor (BAFR) and ibrutinib belongs to a class of therapeutics called Bruton ...
Eli Lilly and Co expects the U.S. Medicare health plan to back down from strict coverage limits on new Alzheimer's drugs as ...
An in-depth review of chronic postfracture pain, detailing prevalence, modifiable risk factors (smoking, obesity), neural/molecular mechanisms, and assessment tools to support non-opioid analgesic ...
GSK plc (LSE/NYSE: GSK) announced that the U.S. Food and Drug Administration has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for adult patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results